Please see full response below
Effect of alpha-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients
Your well-being is worth it
The news: The FDA is stepping up its enforcement on GLP-1 compounding with a new proposal to remove several key active ingredients from the bulk substances list that outsourcing manufacturers are allowed to use to make the copycat diabetes and obesity drugs
TRC Healthcare Editor Hosts: Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC Don Weinberger, PharmD, PMSP Guest: Sara Klockars, PharmD, BCPS (TRC Healthcare Editor) CE Information: None of the speakers have anything to disclose
Our guide on insulin resistance and liver health explains this relationship